Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Oldham

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 11, 2026
Mycophenolate and Azathioprine in Fibrotic Interstitial Lung DiseaseJanelle Vu Pugashetti, Adelle S Jee, Andrew R Yu, et al.
American Journal of Respiratory and Critical Care Medicine|July 4, 2019
Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity PneumonitisBrett Ley, Dara G Torgerson, Justin M Oldham, et al.
The European Respiratory Journal|April 20, 2023
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation studyCarl J Reynolds, Fabiola Del Greco M, Richard J Allen, et al.
BMC Pulmonary Medicine|November 22, 2015
A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosisYong Huang, Shwu-Fan Ma, Rekha Vij, et al.
The New England Journal of Medicine|March 12, 2020
Reversal of TGFβ1-Driven Profibrotic State in Patients with Pulmonary FibrosisHarold A Chapman, Ying Wei, Genevieve Montas, et al.
ERJ Open Research|August 29, 2017
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitisAyodeji Adegunsoye, Justin M Oldham, Evans R Fernández Pérez, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent ValidationAyodeji Adegunsoye, Justin M Oldham, Catherine Bonham, et al.
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung DiseaseYong Huang, Shwu-Fan Ma, Justin M Oldham, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M Maher, Shervin Assassi, Arata Azuma, et al.
Respiratory Research|March 14, 2020
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trialKevin J Anstrom, Imre Noth, Kevin R Flaherty, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
American Journal of Respiratory and Critical Care Medicine|July 11, 2026
Mycophenolate and Azathioprine in Fibrotic Interstitial Lung DiseaseJanelle Vu Pugashetti, Adelle S Jee, Andrew R Yu, et al.
American Journal of Respiratory and Critical Care Medicine|July 4, 2019
Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity PneumonitisBrett Ley, Dara G Torgerson, Justin M Oldham, et al.
The European Respiratory Journal|April 20, 2023
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation studyCarl J Reynolds, Fabiola Del Greco M, Richard J Allen, et al.
BMC Pulmonary Medicine|November 22, 2015
A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosisYong Huang, Shwu-Fan Ma, Rekha Vij, et al.
The New England Journal of Medicine|March 12, 2020
Reversal of TGFβ1-Driven Profibrotic State in Patients with Pulmonary FibrosisHarold A Chapman, Ying Wei, Genevieve Montas, et al.
ERJ Open Research|August 29, 2017
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitisAyodeji Adegunsoye, Justin M Oldham, Evans R Fernández Pérez, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent ValidationAyodeji Adegunsoye, Justin M Oldham, Catherine Bonham, et al.
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung DiseaseYong Huang, Shwu-Fan Ma, Justin M Oldham, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M Maher, Shervin Assassi, Arata Azuma, et al.
Respiratory Research|March 14, 2020
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trialKevin J Anstrom, Imre Noth, Kevin R Flaherty, et al.
Pageof 17